Correlation Between Sunshine Biopharma and Alimera Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sunshine Biopharma and Alimera Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sunshine Biopharma and Alimera Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sunshine Biopharma and Alimera Sciences, you can compare the effects of market volatilities on Sunshine Biopharma and Alimera Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sunshine Biopharma with a short position of Alimera Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sunshine Biopharma and Alimera Sciences.

Diversification Opportunities for Sunshine Biopharma and Alimera Sciences

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between Sunshine and Alimera is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Sunshine Biopharma and Alimera Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alimera Sciences and Sunshine Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sunshine Biopharma are associated (or correlated) with Alimera Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alimera Sciences has no effect on the direction of Sunshine Biopharma i.e., Sunshine Biopharma and Alimera Sciences go up and down completely randomly.

Pair Corralation between Sunshine Biopharma and Alimera Sciences

If you would invest  282.00  in Sunshine Biopharma on September 1, 2024 and sell it today you would earn a total of  4.00  from holding Sunshine Biopharma or generate 1.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy4.76%
ValuesDaily Returns

Sunshine Biopharma  vs.  Alimera Sciences

 Performance 
       Timeline  
Sunshine Biopharma 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Sunshine Biopharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Alimera Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Alimera Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Alimera Sciences is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Sunshine Biopharma and Alimera Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sunshine Biopharma and Alimera Sciences

The main advantage of trading using opposite Sunshine Biopharma and Alimera Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sunshine Biopharma position performs unexpectedly, Alimera Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alimera Sciences will offset losses from the drop in Alimera Sciences' long position.
The idea behind Sunshine Biopharma and Alimera Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios